Topiramate Capsule, Extended Release
Product Images NDC 10370-368

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 10370-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topiramate Er Capsule (Topiramate Extended Release Capsules 200 mg 1)

Chemical structure diagram of the active ingredient Topiramate, showing its molecular framework and functional groups as part of its chemical formula representation.*

FDA Label Image

Topiramate Er Capsule (Topiramate Extended Release Capsules 200 mg 2)

A cumulative rate of time to first seizure graph comparing Topiramate 50 mg/day and 400 mg/day. The y-axis represents cumulative rates, and the x-axis represents time in days. The chart shows two lines indicating seizure occurrence over approximately 500 days, with a noted statistical significance of p = 0.0002.*

FDA Label Image

Topiramate Er Capsule (Topiramate Extended Release Capsules 200 mg 3)

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and three doses of topiramate (50 mg/day, 100 mg/day, 200 mg/day) across two studies. The y-axis shows the change value, and both studies show a greater reduction in migraine rates with increasing topiramate dose compared to placebo, with statistical significance markers indicated.*

FDA Label Image

Topiramate 200 mg (Topiramate Extended Release Capsules 200 mg 4)

Topiramate 200 mg extended-release capsules packaging label by Par Pharmaceutical. The label instructs swallowing the capsule whole and intact and indicates the product contains 30 capsules. It provides storage information at 20° to 25°C, dispensing guidance, and includes a barcode. The capsules have a yellow opaque cap and white opaque body.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.